Similar articles for PMID: 31382121

Year	Number of Results
2003	1
2006	1
2007	7
2008	5
2009	8
2010	4
2011	11
2012	20
2013	12
2014	8
2015	8
2016	7
2017	14
2018	11
2019	20
2020	26
2021	32
2022	22
2023	5
2024	0

1

Human papillomavirus vaccine disease impact beyond expectations.

de Sanjose S, Brotons M, LaMontagne DS, Bruni L. de Sanjose S, et al. Curr Opin Virol. 2019 Dec;39:16-22. doi: 10.1016/j.coviro.2019.06.006. Epub 2019 Aug 2. Curr Opin Virol. 2019. PMID: 31382121 Review.

2

Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs.

Murillo R, Ordóñez-Reyes C. Murillo R, et al. Int J Gynecol Cancer. 2019 Oct;29(8):1317-1326. doi: 10.1136/ijgc-2019-000582. Epub 2019 Aug 26. Int J Gynecol Cancer. 2019. PMID: 31455660 Review.

3

Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.

Poljak M. Poljak M. Clin Microbiol Infect. 2012 Oct;18 Suppl 5:64-9. doi: 10.1111/j.1469-0691.2012.03946.x. Epub 2012 Aug 6. Clin Microbiol Infect. 2012. PMID: 22862799 Free article. Review.

4

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.

Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M. Rogovskaya SI, et al. Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043. Vaccine. 2013. PMID: 24332297

5

Implementation of human papillomavirus immunization in the developing world.

Kane MA, Serrano B, de Sanjosé S, Wittet S. Kane MA, et al. Vaccine. 2012 Nov 20;30 Suppl 5:F192-200. doi: 10.1016/j.vaccine.2012.06.075. Vaccine. 2012. PMID: 23199963 Review.

6

The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?

Patel C, Brotherton JM, Pillsbury A, Jayasinghe S, Donovan B, Macartney K, Marshall H. Patel C, et al. Euro Surveill. 2018 Oct;23(41):1700737. doi: 10.2807/1560-7917.ES.2018.23.41.1700737. Euro Surveill. 2018. PMID: 30326995 Free PMC article. Review.

7

Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.

Simms KT, Steinberg J, Caruana M, Smith MA, Lew JB, Soerjomataram I, Castle PE, Bray F, Canfell K. Simms KT, et al. Lancet Oncol. 2019 Mar;20(3):394-407. doi: 10.1016/S1470-2045(18)30836-2. Epub 2019 Feb 19. Lancet Oncol. 2019. PMID: 30795950

8

Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).

Kim JJ, Sharma M, O'Shea M, Sweet S, Diaz M, Sancho-Garnier H, Seoud M. Kim JJ, et al. Vaccine. 2013 Dec 30;31 Suppl 6:G65-77. doi: 10.1016/j.vaccine.2012.06.096. Vaccine. 2013. PMID: 24331822

9

The epidemiology behind the HPV vaccine discovery.

Koutsky L. Koutsky L. Ann Epidemiol. 2009 Apr;19(4):239-44. doi: 10.1016/j.annepidem.2009.01.023. Ann Epidemiol. 2009. PMID: 19344861 Review.

10

Correlates of human papillomavirus vaccine coverage: a state-level analysis.

Moss JL, Reiter PL, Brewer NT. Moss JL, et al. Sex Transm Dis. 2015 Feb;42(2):71-5. doi: 10.1097/OLQ.0000000000000225. Sex Transm Dis. 2015. PMID: 25585064 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

205 results

Results by year